Identification of hub genes involved in cisplatin resistance in head and neck cancer.

Raushan Kumar Chaudhary Pukar Khanal Uday Venkat Mateti Shastry CsJayarama Shetty

Published in: Journal, genetic engineering & biotechnology (2023)

As the pathogenesis of head and neck cancer is complex, targeting hub genes and associated pathways involved in cisplatin resistance could bring a milestone change in the drug discovery and management of drug resistance which might uplift overall survival among HNC patients.

Keyphrases

bioinformatics analysis
drug discovery
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
genome wide
gene expression
drug delivery